[ad_1]
Washington, DC, March 08, 2022 (GLOBE NEWSWIRE) — This week, the National Association of Specialty Pharmacy’s President and CEO Sheila M. Arquette, RPh, issued comments that laud the Centers for Medicare and Medicaid Services (CMS) for taking steps to reduce out of pocket drug costs for seniors through initial pharmacy Direct and Indirect Remuneration (DIR) reforms. However, NASP urged CMS to do far more to protect patient access to the pharmacy of their choosing and protect specialty pharmacy businesses.
Rising pharmacy DIR fees under Medicare Part D have been harming specialty patients who are living with life-altering and life-threatening medical conditions and the pharmacies that serve them. CMS stated in its Medicare Part D proposed rule that pharmacy price concessions (DIR fees) grew a staggering 107,400 percent between 2010 and 2020, with no savings passed onto Medicare beneficiaries. CMS estimates that the …
Full story available on Benzinga.com
[ad_2]
Source link
